↓ Skip to main content

Dove Medical Press

Lung function efficacy and symptomatic benefit of olodaterol once daily delivered via Respimat® versus placebo and formoterol twice daily in patients with GOLD 2–4 COPD: results from two replicate 48-w…

Overview of attention for article published in International Journal of Chronic Obstructive Pulmonary Disease, July 2014
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (52nd percentile)
  • Above-average Attention Score compared to outputs of the same age and source (52nd percentile)

Mentioned by

policy
1 policy source

Readers on

mendeley
107 Mendeley
Title
Lung function efficacy and symptomatic benefit of olodaterol once daily delivered via Respimat® versus placebo and formoterol twice daily in patients with GOLD 2–4 COPD: results from two replicate 48-week studies
Published in
International Journal of Chronic Obstructive Pulmonary Disease, July 2014
DOI 10.2147/copd.s62502
Pubmed ID
Authors

Andrea Koch, Emilio Pizzichini, Alan Hamilton, Lorna Hart, Lawrence Korducki, Maria Cristina De Salvo, Pierluigi Paggiaro

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 107 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 <1%
Australia 1 <1%
Brazil 1 <1%
Unknown 104 97%

Demographic breakdown

Readers by professional status Count As %
Other 13 12%
Student > Master 11 10%
Researcher 10 9%
Student > Doctoral Student 9 8%
Student > Bachelor 8 7%
Other 30 28%
Unknown 26 24%
Readers by discipline Count As %
Medicine and Dentistry 43 40%
Pharmacology, Toxicology and Pharmaceutical Science 13 12%
Agricultural and Biological Sciences 6 6%
Unspecified 5 5%
Nursing and Health Professions 5 5%
Other 8 7%
Unknown 27 25%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 February 2015.
All research outputs
#8,535,472
of 25,374,647 outputs
Outputs from International Journal of Chronic Obstructive Pulmonary Disease
#1,053
of 2,577 outputs
Outputs of similar age
#80,049
of 242,347 outputs
Outputs of similar age from International Journal of Chronic Obstructive Pulmonary Disease
#10
of 25 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,577 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.5. This one has gotten more attention than average, scoring higher than 54% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 242,347 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 52% of its contemporaries.
We're also able to compare this research output to 25 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 52% of its contemporaries.